Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1341 | Pituitary Basic | ICEECE2012

Effect of estrogen and FGF-2 interaction on lactotroph cell proliferation mediated by membrane-initiated signaling

Sosa L. , Gutierrez S. , Petiti J. , Vaca A. , De Paul A. , Torres A.

Estradiol (E2) may directly interact with growth factors stimulating cell proliferation and differentiation. Previously, we have demonstrated that E2 through membrane estrogen receptor α (mERα) modulates the lactotroph cell population which exhibit noticeable changes in the pituitary gland. The aim of this study was to analyze the mERα contribution on lactotroph cell proliferation in response to E2 and FGF-2 interaction evaluatin...

ea0049ep459 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Maturity-onset diabetes of the young type 5 (mody 5): a case report

Vaca Carlos Silva , Fernandez Elena Garcia , Rodriguez Juan Carlos Romero , Martinez Guillermo

Introduction: MODY 5 is a rare type of dominantly inherited diabetes mellitus. It is asociated with mutations of the hepatocyte nuclear factor-1beta (HNF-1beta) gene. They are mostly missense mutations that produce truncated proteins with a variable clinical spectrum that encompasses among others: kidney, genital and pancreatic abnormalities.Case-report: A 35 years-old man without relevant medical history, presented with acute hypergycemia (541 mg/dl) an...

ea0049ep8 | Adrenal cortex (to include Cushing's) | ECE2017

Corticoids-therapy related complications in patients with primary adrenal insufficiency

Rodriguez Juan Carlos Romero , Gutierrez Maria Calatayud , Reyes Laura Mola , Vaca Carlos Silva , Iglesias Sonsoles Guadalix , Diaz-Guerra Guillermo Martinez

Introduction: Patients with primary adrenal insufficiency (PAI) require lifelong corticoids replacement and they are at risk of therapy-related osteoporosis and cardiovascular complications.Objectives: Determine the prevalence of cardiovascular risk factors, osteoporosis, and other toxicities related with corticoids treatment.Material and methods: Retrospective, descriptive study in patients with PAI follow up in our service during...

ea0070aep438 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer

Silva Vaca Carlos , Males David , Martin Gonzalez Alba , García Elena , Martínez Guillermo , León Miguel

Background: Pancreatic Cancer (PC) is uncommon; however, it is one of the most deadly cancer types of all. New-onset diabetes (NOD) is associated with a higher risk of pancreatic cancer than general population, particularly if late-onset. An association between new-onset diabetes and increased mortality in patients with pancreatic cancer has been suggested but clinical relevant differences between those individuals with new-onset diabetes and those without are not well establi...